Two-dose HPV vaccines at younger age are noninferior to standard three-dose vaccine

Girls who receive a two-dose regimen of human papillomavirus (HPV)–16/18 AS04-adjuvanted vaccine at any age between 9 and 14 years, in either a 6-month or a 12-month interval, appear to be equally protected as those who received a 6-month, three-dose regimen at the age of 15-25 years, according to...
Source: Skin and Allergy News - Category: Dermatology Source Type: news